Scientist, Biology at Gilead Sciences

Foster City, California, United States

Gilead Sciences Logo
Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, PharmaceuticalsIndustries

Requirements

  • Bachelor's Degree and 6 years experience OR Master's Degree and 4 years experience
  • Ph.D. in immunology, molecular/cell biology, biochemistry, or a related field with at least 2 years of postdoctoral experience, or a Master’s degree with 8–10 years of relevant industry experience (preferred)
  • Deep expertise in T cell biology, immune tolerance, and regulatory T cell function
  • Hands-on experience with T cell engineering, including CRISPR and other gene-editing platforms
  • Familiarity with preclinical in vivo models of inflammation or autoimmunity (preferred)
  • Strong scientific track record demonstrated by first-author publications in high-impact journals
  • Excellent communication, collaboration, and organizational skills

Responsibilities

  • Design and execute in vitro and in vivo studies to explore mechanisms of immune tolerance
  • Develop and evaluate innovative therapeutic strategies, including engineered Treg and other cellular therapies
  • Utilize CRISPR and other gene-editing tools to engineer T cells for exploratory and therapeutic applications
  • Establish and optimize preclinical models to assess immune modulation and therapeutic efficacy
  • Collaborate across multidisciplinary teams including immunology, biochemistry, medicinal chemistry, and bioinformatics
  • Present findings to internal teams and leadership; contribute to publications, patents, and regulatory submissions
  • Stay current with emerging technologies and scientific literature to drive innovation

Skills

T cell biology
in vivo modeling
T cell engineering
immune tolerance
regulatory T cell biology
in vitro studies
in vivo studies

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters
1987Year Founded
$15,873.6MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Paid family time off and paid parental time off
Generous 401(k) contribution matching
Comprehensive medical plans that cover both physical and mental healthcare
Global Wellbeing Reimbursement
Time Off
Global Volunteer Day
Giving Together Program
Employee Support Programs
Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.
Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.
Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.
Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.
Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.
Investment in digital health technologies enhances Gilead's R&D and patient engagement.
Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI